PeptiDream has signed a deal with fellow Japanese pharmaceutical company Shionogi to discover and develop a series of blood-brain barrier (BBB) penetrating peptide drug conjugates.
Finnish drug delivery company DelSiTech has signed a licensing agreement with Mexico-based pharmaceutical group Innovare to develop a long-acting human immunodeficiency virus (HIV) therapy......